Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Human CD81 has been previously identified as the putative receptor for the hepatitis C virus envelope glycoprotein E2. The large extracellular loop (LEL) of human CD81 differs in four amino acid residues from that of the African green monkey (AGM), which does not bind E2. We mutated each of the four positions in human CD81 to the corresponding AGM residues and expressed them as soluble fusion LEL proteins in bacteria or as complete membrane proteins in mammalian cells. We found human amino acid 186 to be critical for the interaction with the viral envelope glycoprotein. This residue was also important for binding of certain anti-CD81 monoclonal antibodies. Mutating residues 188 and 196 did not affect E2 or antibody binding. Interestingly, mutation of residue 163 increased both E2 and antibody binding, suggesting that this amino acid contributes to the tertiary structure of CD81 and its ligand-binding ability. These observations have implications for the design of soluble high-affinity molecules that could target the CD81-E2 interaction site(s).

Type

Journal article

Journal

J Virol

Publication Date

04/2000

Volume

74

Pages

3642 - 3649

Keywords

Amino Acid Sequence, Animals, Antibodies, Monoclonal, Antibody Affinity, Antigen-Antibody Complex, Antigens, CD, Binding Sites, Cell Line, Cercopithecus aethiops, Hepacivirus, Humans, Membrane Proteins, Molecular Sequence Data, Point Mutation, Protein Conformation, Receptors, Cell Surface, Recombinant Fusion Proteins, Tetraspanin 28, Thiocyanates, Viral Envelope Proteins